Advanced therapeutics, vaccinations, and precision medicine in the treatment and management of chronic hepatitis b viral infections; where are we and where are we …

GS Duraisamy, D Bhosale, I Lipenská, I Huvarova… - Viruses, 2020 - mdpi.com
The management of chronic hepatitis B virus (CHB) infection is an area of massive unmet
clinical need worldwide. In spite of the development of powerful nucleoside/nucleotide …

Genomics and infectious disease: a call to identify the ethical, legal and social implications for public health and clinical practice

G Geller, R Dvoskin, CL Thio, P Duggal, MH Lewis… - Genome medicine, 2014 - Springer
Advances in genomics are contributing to the development of more effective, personalized
approaches to the prevention and treatment of infectious diseases. Genetic sequencing …

[HTML][HTML] Common genetic variants identify therapeutic targets for COVID-19 and individuals at high risk of severe disease

JE Horowitz, JA Kosmicki, A Damask, D Sharma… - MedRxiv, 2020 - medrxiv.org
The need to identify and effectively treat COVID-19 cases at highest risk for severe disease
is critical. We identified seven common genetic variants (three novel) that modulate COVID …

GWAS identifying HLA‐DPB1 gene variants associated with responsiveness to hepatitis B virus vaccination in Koreans: Independent association of HLA‐DPB1* 04 …

S Chung, EY Roh, B Park, Y Lee, S Shin… - Journal of Viral …, 2019 - Wiley Online Library
Recently, HLA class II loci, including HLA‐DPB1, have been reported to be associated with
interindividual variance in the hepatitis B (HB) vaccine response. In this study, we …

Beyond metabolism: role of the immune system in hepatic toxicity

KL Hastings, MD Green, B Gao… - … journal of toxicology, 2020 - journals.sagepub.com
The liver is primarily thought of as a metabolic organ; however, the liver is also an important
mediator of immunological functions. Key perspectives on this emerging topic were …

Quantitative assessment of common genetic variations in HLA-DP with hepatitis B virus infection, clearance and hepatocellular carcinoma development

L Yu, Y Cheng, M Cheng, Y Yao, Q Zhang, X Zhao… - Scientific reports, 2015 - nature.com
Hepatitis B virus (HBV) infection is the predominant risk factor for chronic hepatitis B (CHB),
liver cirrhosis (LC) and hepatocellular carcinoma (HCC). Recently, genome-wide …

A missense variant in complement factor B (CFB) is a potential predictor of 24‐week off‐treatment response to PegIFNα therapy in Chinese HBeAg‐positive chronic …

H Chen, J Sun, B Zhou, J Peng, Q Xie… - Alimentary …, 2020 - Wiley Online Library
Background To date, 14 single‐nucleotide polymorphisms (SNPs) have been identified as
susceptibility loci for chronic hepatitis B (CHB). Aim To investigate if these SNPs are …

Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci of STAT4 and HLA-DQ in a Korean population

LH Kim, HS Cheong, S Namgoong, JO Kim… - Infection, Genetics and …, 2015 - Elsevier
A recent genome-wide association study (GWAS) for hepatitis B virus (HBV)-related
hepatocellular carcinoma (HCC) identified two loci (rs7574865 in STAT4 and rs9275319 in …

Genetic insights on host and hepatitis B virus in liver diseases

H van Tong, CT Bock, TP Velavan - Mutation Research/Reviews in …, 2014 - Elsevier
Hepatitis B virus (HBV) infection is a major global health problem and many studies have
underlined the importance of inter individual variability and somatic mutations during the …

Genome-wide association study for chronic hepatitis B infection in the Thai Population

S Ashouri, SS Khor, Y Hitomi, H Sawai… - Frontiers in …, 2022 - frontiersin.org
To identify novel host genetic variants that predispose to hepatitis B virus (HBV) persistence,
we performed the first genome-wide association study in the Thai population involving 318 …